These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Lack of publication bias related to results from trastuzumab study. Perez EA; Suman VJ Lancet; 2008 Aug; 372(9639):626-7. PubMed ID: 18722859 [No Abstract] [Full Text] [Related]
5. Herceptin (trastuzumab): adjuvant and neoadjuvant trials. Yaal-Hahoshen N; Safra T Isr Med Assoc J; 2006 Jun; 8(6):416-21. PubMed ID: 16833172 [No Abstract] [Full Text] [Related]
6. [Breast cancer: adjuvant therapy with trastuzumab: herceptin adjuvant (HERA) Trial Study, B-31- and N9831-Study]. Mallmann P Internist (Berl); 2006 Nov; 47(11):1183-5. PubMed ID: 17048017 [No Abstract] [Full Text] [Related]
7. A meta-analysis of randomized controlled trials comparing chemotherapy plus trastuzumab with chemotherapy alone in HER-2-positive advanced breast cancer. Liao C; Yin F; Huang P; Cao Y; Gao F Breast J; 2011; 17(1):109-11. PubMed ID: 21129096 [No Abstract] [Full Text] [Related]
8. Trastuzumab in breast cancer. Gounaris IG N Engl J Med; 2006 Feb; 354(6):640-4; author reply 640-4. PubMed ID: 16470950 [No Abstract] [Full Text] [Related]
13. [Clinical implications of trastuzumab]. Saeki T; Takashima S Gan To Kagaku Ryoho; 2003 Aug; 30(8):1094-9. PubMed ID: 12938263 [TBL] [Abstract][Full Text] [Related]
14. Trastuzumab in the treatment of breast cancer. Hortobagyi GN N Engl J Med; 2005 Oct; 353(16):1734-6. PubMed ID: 16236745 [No Abstract] [Full Text] [Related]
15. HER2 status and benefit from adjuvant trastuzumab in breast cancer. Paik S; Kim C; Wolmark N N Engl J Med; 2008 Mar; 358(13):1409-11. PubMed ID: 18367751 [No Abstract] [Full Text] [Related]
17. Improved prognosis by trastuzumab of women with HER2-positive breast cancer compared with those with HER2-negative disease. Ferretti G; Fabi A; Felici A; Papaldo P J Clin Oncol; 2010 Jul; 28(20):e337; author reply e338-9. PubMed ID: 20479395 [No Abstract] [Full Text] [Related]
18. Trastuzumab (herceptin) for early-stage breast cancer. Ismael G; Rosa DD; de Azambuja E; Braga S; Piccart-Gebhart M Hematol Oncol Clin North Am; 2007 Apr; 21(2):239-56. PubMed ID: 17512447 [TBL] [Abstract][Full Text] [Related]
19. Trastuzumab beyond disease progression: case closed? Valabrega G; Aglietta M; Montemurro F J Clin Oncol; 2009 Sep; 27(27):e121-2; author reply e124-5. PubMed ID: 19687323 [No Abstract] [Full Text] [Related]